NCT00470080

Brief Summary

This randomized bicentric trial will investigate the efficacy of topical EMLA cream with oral sucrose solution compared to oral sucrose solution alone before venepuncture in preterm infants.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for phase_4 pain

Timeline
Completed

Started Jun 2007

Shorter than P25 for phase_4 pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 4, 2007

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 7, 2007

Completed
25 days until next milestone

Study Start

First participant enrolled

June 1, 2007

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2007

Completed
Last Updated

May 4, 2011

Status Verified

May 1, 2007

Enrollment Period

5 months

First QC Date

May 4, 2007

Last Update Submit

May 3, 2011

Conditions

Keywords

VenepuncturePainEmla creamOral sucrose solutionPremature infantPremature infant admitted to the care baby unit wereincluded in the study.Programed venepuncture is performed with analgesia.

Outcome Measures

Primary Outcomes (1)

  • Association of oral sucrose solution and EMLA cream will reduce pain responses in premature infant for venepuncture.A combination of physiological and behavioural responses are used for the measurement of pain in neonates : DAN score and PIPP.

    Association of oral sucrose solution and EMLA cream will reduce pain responses in premature infant for venepuncture.A combination of physiological and behavioural responses are used for the measurement of pain in neonates : DAN score and PIPP.

    in 24 hours

Secondary Outcomes (1)

  • Clinical units providing health care in newborns develop written guidelines and protocols for the management of neonatal pain, like venepuncture with the combination of sucrose oral solution and EMLA cream.

    in the 24 hours

Study Arms (1)

1

EXPERIMENTAL

venepuncture

Procedure: venepuncture

Interventions

venepuncturePROCEDURE

venepuncture

1

Eligibility Criteria

Age26 Weeks - 37 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • preterm infants (gestational age between 26 and 37 weeks)
  • programmed venepuncture
  • APGAR score (M5)≥ 7
  • enteral feeding
  • written parental consent

You may not qualify if:

  • infant requiring oxygen
  • analgesia or sedation or drugs causing methaemoglobinaemia
  • congenital porphyria
  • G6PD deficit
  • multi organ failure
  • convulsion
  • dermatosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Armand Trousseau

Paris, 75012, France

Location

Related Publications (2)

  • Acharya AB, Annamali S, Taub NA, Field D. Oral sucrose analgesia for preterm infant venepuncture. Arch Dis Child Fetal Neonatal Ed. 2004 Jan;89(1):F17-8. doi: 10.1136/fn.89.1.f17. No abstract available.

  • Acharya AB, Bustani PC, Phillips JD, Taub NA, Beattie RM. Randomised controlled trial of eutectic mixture of local anaesthetics cream for venepuncture in healthy preterm infants. Arch Dis Child Fetal Neonatal Ed. 1998 Mar;78(2):F138-42. doi: 10.1136/fn.78.2.f138.

MeSH Terms

Conditions

PainPremature Birth

Interventions

Blood Specimen Collection

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsObstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • Valérie BIRAN, MD

    Assistance Publique - Hôpitaux de Paris

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

May 4, 2007

First Posted

May 7, 2007

Study Start

June 1, 2007

Primary Completion

November 1, 2007

Study Completion

November 1, 2007

Last Updated

May 4, 2011

Record last verified: 2007-05

Locations